search 2013 adfgs

Diagnostics and Personalized Medicine Innovation Summit

BioNJ 2013 Dx&PM Innovation Summit

Thursday, June 6, 2013
Sanofi
Bridgewater, NJ

 

Keynote Speakers

G. Steven Burrill
CEO
Burrill & Company
Edward Abrahams, Ph.D.
President
Personalized Medicine Coalition
Elias Zerhouni, M.D.
President, Global R&D
Sanofi

Agenda

Please mark your calendar for Thursday, June 6, 2013 and join us at Sanofi Headquarters in Bridgewater, NJ, from 8:30 a.m. to 4:30 p.m. for the Second Annual Diagnostics & Personalized Medicine Innovation Summit.

This annual event continues our focus on the innovation and evolution of diagnostic tools and the important contributions being made by the New Jersey life sciences community to realizing the promise of personalized medicine.

Last year’s Summit was at full capacity, so BioNJ is expanding the event for 2013. By popular request, we are extending the Summit from a half-day to a full-day event.

 

8:00 a.m. – 8:45 a.m. Registration and Networking Breakfast
8:45 a.m. – 9:45 a.m. Welcome and Keynote Presentation
Research and Development in a New Era
Elias Zerhouni, M.D., President, Global R&D, Sanofi
9:45 a.m. – 10:30 a.m. Panel Discussion
What will gain market traction next in personalized medicine and treatment? Where should companies and investors focus time?Moderator:
Panna Sharma, President and CEO, Cancer Genetics, Inc.
Panelists:
G. Steven Burrill, CEO, Burrill & Company
Kevin DeGeeter, Managing Director, Personalized Medicine Research Analyst,  Ladenburg Thalmann & Co.
Sung Ji Nam, Senior Equity Research Analyst, Cantor Fitzgerald
Frank Prendergast, M.D., Ph.D., Professor of Biochemistry & Molecular Biology and Professor of  Molecular Pharmacology & Experimental Therapeutics, The Mayo Clinic 
10:30 a.m. – 11:00 a.m. Networking Break and Poster Session
11:00 a.m. – 11:35 a.m. Company Presentations
11:35 a.m. – 12:20 p.m. Keynote Presentation
Biotech/Pharma 2013: Value and Outcomes
G. Steven BurrillCEO, Burrill & Company 
12:20 p.m. – 1:50 p.m. Funding Roundtable Luncheon and Poster Session
1:50 p.m. – 2:20 p.m. Keynote Presentation
Personalized Medicine: The Changing Landscape of Health Care
Edward Abrahams, Ph.D., President, Personalized Medicine Coalition
2:20 p.m. – 3:05 p.m. Panel Discussion
The Role of Diagnostics in Translational Medicine
Moderator:
Samir Tari, M.D., Founder and CEO, PCAsso Diagnostics LLC
Panelists:
Salvatore Salamone, Ph.D., Founder, Senior Vice President and Chief Scientific Officer, Saladax Biomedical
Ger Brophy, Ph.D., Vice President, New Product Development, GE Healthcare Medical Diagnostics
Sean Hu, Ph.D., Managing Director, Bionest Partners
3:05 p.m. – 3:25 p.m. Networking Break and Poster Session
3:25 p.m. – 3:45 p.m. Keynote Presentation
Innovations in Circulating Tumor Cell Technology
Robert McCormack, Ph.D., Head of Cellular R&D and Technology Innovation and Strategy, Veridex
3:45 p.m. – 4:05 p.m. Personalized Medicine Awareness
Dean Sproles, CEO, Iverson Genetic Diagnostics
4:05 p.m. – 4:45 p.m. Networking

Present Your Technology

Selected diagnostic, biopharmaceutical and medical technology companies will have an opportunity to present their technologies to conference attendees.

Please CLICK HERE for the presentation application.

Video Highlights the Importance of Attending

BioNJ invites you to enjoy a video, featuring Shiv Krishnan, Ph.D., Senior Director, Scouting & Partnering – US at Sanofi R&D that addresses the importance of attending the BioNJ Personalized Medicine Innovation Summit.

This event is an excellent opportunity for industry leaders to meet, present, network and learn about the exciting new area of personalized medicine and the promise it holds for the future of the life sciences industry.


Sponsorship Opportunities Available

This is a unique opportunity for sponsors.
Make sure your company gets involved by contacting BioNJ today!

Contact:

Kathleen Otto
Vice President, Business Development, BioNJ
KOtto@BioNJ.org

609-890-3185

Registration